The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial

• Published in: Acta Cardiologica Vol. ahead-of-print; no. ahead-of-print; pp. 1 - 6
• Main Authors: Hayıroğlu, Mert İlker, Çınar, Tufan, Cilli Hayıroğlu, Selin, Şaylık, Faysal, Uzun, Mehmet, Tekkeşin, Ahmet İlker
• Format: Journal Article
• Language: English
• Published: Taylor & Francis 01-11-2023
• Subjects: cardiopulmonary exercise test; digital health intervention; Mobile application
• ISSN: 0001-5385; 1784-973X
• DOI: 10.1080/00015385.2023.2223005

This investigation aims to assess the influence of a mobile application and smart devices on cardiopulmonary exercise testing (CPET) over a one-year period in individuals who have high risk for cardiovascular disease.
This is a post-hoc subgroup analysis of Lifestyle Intervention Using Mobile Technology in Patients with High Cardiovascular Risk: A Pragmatic Randomised Clinical Trial (LIGHT). In the intervention plus standard care standard standard care arms, 138 and 103 patients were recruited, respectively. The 1-year VO
2
measurements were adjusted to the baseline VO
2
measurements as the study's endpoint. VO
2
measurements were taken for each subject during the randomisation and final CPET examinations.
The intervention plus standard care improved VO
2
measurements by 1.1 (adjusted treatment effect 1.1, 95% confidence interval (CI): 0.8, 1.4, p < 0.001) compared to standard care following 1-year follow-up.
At a 1-year follow-up, the smart device and mobile application technologies increased VO
2
measurements in individuals with high cardiovascular risk compared to conventional treatment alone.